| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/16/2006 | US20060057153 Method and composition for the inhibition of mitosis |
| 03/16/2006 | US20060057136 Immunotherapy of B-Cell malignancies using anti-CD22 antibodies |
| 03/16/2006 | US20060057133 Topical pathogenic-tissue-destroying liquid |
| 03/16/2006 | US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 03/16/2006 | US20060057119 Biologic skin repair and enhancement |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057111 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 03/16/2006 | US20060057109 Method of using anti-apoptotic factors in gene expression |
| 03/16/2006 | US20060057108 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment |
| 03/16/2006 | US20060057104 Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses |
| 03/16/2006 | US20060057099 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/16/2006 | US20060057098 Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide |
| 03/16/2006 | US20060057093 Preparation for topical use with the function of combating hair loss |
| 03/16/2006 | US20060057076 Oral humectants |
| 03/16/2006 | US20060057074 Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| 03/16/2006 | US20060057073 Wet granulation process |
| 03/16/2006 | US20060057067 inhibiting cerebrospinal fluid (CSF) production; repeatedly removing CSF from subarachnoid space and replacing CSF by infusing a lymph-like fluid composition into space; neuro-cardiopulmonary resuscitation; artificial CSF is polypeptides (gelatins), ionic magnesium (Mg2+), ATP, and insulin; mild acidosis |
| 03/16/2006 | US20060057065 Composition and method to prevent and treat brain and spinal cord injuries |
| 03/16/2006 | DE10394214T5 Methyl-B-Orcinolcarboxylat aus Flechten (Everniastrum cirrhatum) zur Verwendung für die Behandlung von Pilzinfektionen und Krebs Methyl-B-Orcinolcarboxylat from lichens (Everniastrum cirrhatum) for use in the treatment of fungal infections and cancer |
| 03/16/2006 | DE102004045037A1 Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform Pharmaceutical dosage forms with aggravated extractability of a sympathomimetic agent from the dosage form |
| 03/16/2006 | DE102004044221A1 Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 3-methyl-xanthine-7-butynyl, their preparation and their use as medicaments |
| 03/16/2006 | DE102004040014A1 New aureonitrile compounds useful as cytostatic agents, fungicides and antibiotics |
| 03/16/2006 | DE102004038328A1 Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten New uses of 2-phenyl-substituted derivatives imidazotriazinone |
| 03/16/2006 | DE102004038270A1 Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-amino-xanthine, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004038269A1 Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-piperidino xanthine, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004038268A1 Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-pyrrolidino-xanthines, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004038155A1 Physiologisch verträgliche Zusammensetzung enthaltend alpha-Liponsäure, Kreatin und ein Phospholipid Physiologically acceptable composition comprising alpha-lipoic acid, creatine and a phospholipid |
| 03/16/2006 | DE102004037554A1 Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-aminoalkylthio-xanthines, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004037445A1 New indolizine and azaindolizine carboxamide derivatives, useful for treating e.g. schizophrenia and urinary incontinence, are ligands for serotinergic receptors |
| 03/16/2006 | DE102004035978A1 New aminoadamantane derivatives useful for treating e.g. viral diseases, Parkinson's disease, Huntington's chorea, Alzheimer's disease, autism, tinnitus, Tourette syndrome, hypertension, sleep disorders and psychosis |
| 03/16/2006 | DE102004035808A1 Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen Ammonium salts and ammonium salt Mineralsalzchlatrate as transport and active form for pharmaceutical and medical-phase transfer agent for chemical applications |
| 03/16/2006 | DE102004035742A1 N-Phenylphosphorsäuretriamide, Verfahren zu ihrer Herstellung und deren Verwendung als Mittel zur Regulierung bzw. Hemmung der enzymatischen Harnstoff-Hydrolyse N-phenyl phosphoric acid, process for their preparation and their use as agents for regulation or inhibition of the enzymatic urea hydrolysis |
| 03/16/2006 | DE102004027871B3 Verfahren zur Herstellung von 10α-[4'-(S,S-Dioxothiomorpholin-1'-yl)]-10-desoxo-10-dihydroartemisinin Process for the preparation of 10α- [4 '- (S, S-Dioxothiomorpholin-1'-yl)] - 10-deoxo-10-dihydroartemisinin |
| 03/16/2006 | CA2591321A1 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| 03/16/2006 | CA2583375A1 Regulation of oncogenes by micrornas |
| 03/16/2006 | CA2580132A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 03/16/2006 | CA2580042A1 Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 03/16/2006 | CA2580034A1 Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds |
| 03/16/2006 | CA2580024A1 Therapeutic diphenyl ether ligands |
| 03/16/2006 | CA2580019A1 Pharmaceutical composition comprising an isomer of a betamimetic agent and an anti-cholinergic agent |
| 03/16/2006 | CA2579889A1 Thiazole derivatives having vap-1 inhibitory activity |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2579805A1 Methods for transmembrane treatment and prevention of otitis media |
| 03/16/2006 | CA2579786A1 Use of liposomal glucocorticoids for treating inflammatory states |
| 03/16/2006 | CA2579768A1 Enzyme inhibitors and uses thereof |
| 03/16/2006 | CA2579732A1 Tablets with site time-controlled gastrointestinal release of active ingredient |
| 03/16/2006 | CA2579720A1 A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 03/16/2006 | CA2579695A1 Liposomal compositions of glucocorticoid and glucocorticoid derivatives |
| 03/16/2006 | CA2579660A1 Beta-glucuronidase cleavable prodrugs of o6-alkylguanine-dna alkyltransferase inactivators |
| 03/16/2006 | CA2579621A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 03/16/2006 | CA2579583A1 Silver dihydrogen citrate compositions |
| 03/16/2006 | CA2579576A1 Improved ghb compositions |
| 03/16/2006 | CA2579567A1 Compositions and methods relating to novel compounds and targets thereof |
| 03/16/2006 | CA2579540A1 The treatment of inflammatory disorders and pain |
| 03/16/2006 | CA2579533A1 Drug delivery from embolic agents |
| 03/16/2006 | CA2579488A1 Glycosylceramide adjuvant for saccharide antigens |
| 03/16/2006 | CA2579378A1 Treatment of diseases using nalmefene and its analogs |
| 03/16/2006 | CA2579356A1 Vitamin b6 related compounds and methods for recovery from trauma |
| 03/16/2006 | CA2579353A1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 03/16/2006 | CA2579352A1 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| 03/16/2006 | CA2579338A1 A topical medicament comprising menthol,camphor,potassium, and a source of oxygen |
| 03/16/2006 | CA2579303A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity |
| 03/16/2006 | CA2579302A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | CA2579243A1 Cationic antiseptic compositions and methods of use |
| 03/16/2006 | CA2579231A1 Anti-tumor compounds with angeloyl groups |
| 03/16/2006 | CA2579230A1 Fibrate compounds having ppar agonist activity |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2579059A1 Chemical compounds |
| 03/16/2006 | CA2579030A1 Controlled and directed local delivery of anti-inflammatory compositions |
| 03/16/2006 | CA2579017A1 Roflumilast and syk inhibitor combination and methods of use thereof |
| 03/16/2006 | CA2579007A1 Ciclesonide and syk inhibitor combination and methods of use thereof |
| 03/16/2006 | CA2579000A1 Novel 3-thia-10-aza-phenanthrene derivatives |
| 03/16/2006 | CA2578999A1 Use of thyroid hormone conversion inhibitors |
| 03/16/2006 | CA2578996A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | CA2578990A1 Combination of a 5-ht(1) receptor agonist and an alpha-2-delta ligand for the treatment of migraine |
| 03/16/2006 | CA2578975A1 2-amino 1h imidazo ring systems and methods |
| 03/16/2006 | CA2578958A1 Acetylated starch or starch succinate for treatment of obesity or diabetes |
| 03/16/2006 | CA2578952A1 Waxy corn starch and use thereof for treating obesity and diabetes |
| 03/16/2006 | CA2578933A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | CA2578841A1 Inhibitors of the hiv integrase enzyme |
| 03/16/2006 | CA2578789A1 Substituted heterocyclic compounds and uses thereof |
| 03/16/2006 | CA2578775A1 Methods and compositions for inhibition of innate immune responses and autoimmunity |
| 03/16/2006 | CA2578741A1 1-alkoxy 1h-imidazo ring systems and methods |
| 03/16/2006 | CA2578739A1 Quinazolines useful as modulators of ion channels |
| 03/16/2006 | CA2578702A1 Method of wound healing using a2b adenosine receptor antagonists |
| 03/16/2006 | CA2578540A1 Opioid dosage forms having dose proportional steady state cave and auc and less than dose proportional single dose cmax |
| 03/16/2006 | CA2578434A1 2-morpholino-4-pyrimidone compound |
| 03/16/2006 | CA2578395A1 Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction |
| 03/16/2006 | CA2578384A1 Novel pyrazolopyrimidines |
| 03/16/2006 | CA2578302A1 Composition and method for inducing or restoring locomotor functions in an animal |
| 03/16/2006 | CA2578290A1 Combination of organic compounds |
| 03/16/2006 | CA2578231A1 Sulpiride derivatives pharmaceutical compositions |
| 03/16/2006 | CA2578225A1 Testosterone gels comprising propylene glycol as penetration enhancer |
| 03/16/2006 | CA2578164A1 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
| 03/16/2006 | CA2578159A1 Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
| 03/16/2006 | CA2578052A1 Methods of activating nkt cells |
| 03/16/2006 | CA2577861A1 Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/16/2006 | CA2577634A1 Synthesis of triethylenetetramines |
| 03/16/2006 | CA2577610A1 Sigma receptor ligands |
| 03/16/2006 | CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |